Kinlytic update seems suspect to meKinlytic update seems suspect to me.
Don’t some of the big pharma’s have billions of dollars at their disposal? With distribution networks and manufacturing facilities in place. Why are none of them interested?
Is the best possible partner candidate a grass roots group that has none of its own money? Is the letter of intent going to be riddled with subject too’s? Like subject too that we will partner with microbix on kinlytic provided that we get funding and cooperation at a) The state level and b) the municipal level.
Subject too c)that we can find an approved manufacturing site.
Subject too d) That we can secure financing from our interested investor’s
Seems like this group has a lot of the same problems in bringing the drug to market as microbix has other than they have experience in the thrombolytic field